Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital

BACKGROUND: Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults with acute bacterial skin and skin structure infections (ABSSSI). Its concentration-dependent activity and prolonged half-life provide a convenient...

Descripción completa

Detalles Bibliográficos
Autores principales: Saddler, Kimberly, Zhang, Jason, Sul, Jennifer, Patel, Pruthvi, Castro-Lainez, Miriams, Stevens, Mark L., Kosler, Sheryl, Lowery, Emily, Sierra-Hoffman, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971560/
https://www.ncbi.nlm.nih.gov/pubmed/33735185
http://dx.doi.org/10.1371/journal.pone.0248129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971560/
https://www.ncbi.nlm.nih.gov/pubmed/33735185
http://dx.doi.org/10.1371/journal.pone.0248129

Ejemplares similares